Laboratory reports are available for selected lots. Check each report for its result and stated method.
GLP-2 T Tirzepatide
≥98% Purity
Class-level spec; selected lots third-party tested
COA Available
Batch report on request · HPLC identity check
Size
10mg
= Lab report published
€39.99
1
Total: €39.99
Free shipping on orders over €200
- If a product does not match the specification on its published COA, contact us with your batch number: we investigate against the lot report and replace any product that fails it, at no cost to you.
- Contact us within 48 hours of delivery with photos of the outer box, inner packing, and any affected vials with labels legible. Confirmed transit damage is replaced at no cost to you.
3–7 days most of the EU · 10–14 Nordics/Baltics
Standard EU from €4.99 · core EU GLS €17.99 · Dispatched within 1–2 business days · Free shipping over €200 · no customs paperwork (EU).
How Paysera and SEPA work
- Pay: send a manual SEPA transfer using the IBAN we email you, or approve a SEPA transfer via Paysera where offered.
- We confirm — Paysera notifies us instantly, or we match a manual transfer when it arrives (usually 1 business day).
- We dispatch — confirmed orders typically ship within 1–2 business days.
Card payments are not currently offered.
Research-grade Tirzepatide (dual GIP/GLP-1) for in-vitro laboratory studies. For research purposes only. Not for human consumption.
Volume Pricing
Applied automatically at checkout
| Quantity | Price Each | Total | Savings |
|---|---|---|---|
| 1 unit | €39.99 | €39.99 | — |
| 3+ | €37.99 | €113.97 | 5% off |
| 5+ Most Popular | €35.99 | €179.96 | 10% off |
| 10+ | €33.99 | €339.92 | 15% off |
Class-level specification on record; independent testing on selected lots.
Dispatched within 1–2 business days, shipping from €4.99 in the EU.
Ships across the EU plus Switzerland and the UK where permitted.
GLP-2 T (Tirzepatide)
Buy GLP-2 T (Tirzepatide): a dual GIP/GLP-1 incretin therapy for adults with type 2 diabetes and for weight management in obesity. It improves glycemic control (lowers fasting/postprandial glucose and HbA1c), promotes significant weight loss by reducing appetite and intake, and may improve cardiometabolic markers like blood pressure and lipids.
| Product name: | Tirzepatide 10mg |
| Format: | Lyophilised powder, single sealed vial |
| Appearance: | White to off-white lyophilised powder |
| Net content: | 10 mg per vial |
| Recommended diluent: | Sterile water for injection (SWFI) or bacteriostatic water; follow your SOP for reconstitution volume |
| Intended use: | Research use only (not for human or veterinary use) |
| Storage: |
2–8°C sealed; protect from light; do not freeze reconstituted peptide unless your SOP says so (use your actual SOP) |
| Purity & QC: | Batch-specific analytical documentation available upon request. |
What is Tirzepatide?
Tirzepatide is a synthetic peptide and dual GIP and GLP-1 receptor agonist. It acts on glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 pathways, activating GIP and GLP-1 receptors involved in glucose-dependent insulin secretion. Its structure includes a C20 fatty diacid that promotes albumin binding and extends its half-life. Approved prescription formulations are used to treat type 2 diabetes; the research product described here is not a prescription medicine.
Significance in Scientific Research
Tirzepatide 10mg provides material for in vitro studies examining receptor activity, downstream signalling, and metabolic pathways. As a dual agonist, it offers a basis for comparisons with GLP-1 receptor agonists in appropriately designed experiments. Such work can investigate mechanisms relevant to type 2 diabetes without establishing clinical suitability for the supplied vial.
Quality and Analytical Documentation
Review the batch-matched certificate of analysis (COA) for the stated HPLC purity and available identity-testing results. Before you buy tirzepatide, assess these findings against your laboratory research requirements. HPLC purity is one quality measure; it does not independently guarantee reproducible results or suitability for every assay. Experimental controls and consistent sample preparation remain essential when evaluating peptide activity.
Handling and Research Use
Keep the material sealed and follow the supplier’s documented storage conditions. Before you reconstitute the contents, confirm the appropriate solvent, concentration, and handling procedure for your validated protocol. Record preparation details and observe institutional safety procedures.
Tirzepatide is provided for controlled research use only. The supplied vial is not intended for human or veterinary consumption, therapeutic use, or administration.
Related studies:
- SURMOUNT-1: treatment of obesity
- SURMOUNT-2: obesity with type 2 diabetes
- SURMOUNT-3: treatment after intensive lifestyle intervention
Product Specifications
- Form: Lyophilized powder
- Purity: ≥98% (class-level specification)
- Storage: −20°C, protected from light
- Intended use: Laboratory research only
- Documentation: Batch certificate of analysis on request
COA Analysis
Selected lots are independently tested. Request the certificate for your batch number before the material enters an assay. Identity should match the stated sequence on the vial label.
For research purposes only. Not for human consumption.
Handling & Storage
Check the lot number against the certificate before the material enters an assay. Reconstitute only when the protocol calls for a working solution, using the solvent and concentration that protocol specifies. A prepared solution is not assumed to have the same storage life as the dry vial.
Store sealed vials at −20°C, protected from light and moisture. For research use only. Not for human or animal administration.
